J8501 HCPCS Level II code: Aprepitant, oral, 5 mg
J8501 is the HCPCS code for “Aprepitant, oral, 5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J8501Aprepitant, oral, 5 mg
Short description: Oral aprepitant
HCPCS · United States
Notes for J8501
As CMS prints them, with any note J8501 takes from the headings above it.
Note
- CMS processing note 0119: SEE NCDM REFERENCE 110.17.
Medicare details
The indicators CMS publishes with J8501 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2005
Where J8501 sits
- 1J codesDrugs administered other than orally
- 2Active code J8501Aprepitant, oral, 5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J8501 mean?
J8501 is the HCPCS code for “Aprepitant, oral, 5 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J8501?
CMS lists J8501’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J8501
All J codesJ7686Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mgJ7699Noc drugs, inhalation solution administered through dmeJ7799Noc drugs, other than inhalation drugs, administered through dmeJ7999Compounded drug, not otherwise classifiedJ8498Antiemetic drug, rectal/suppository, not otherwise specifiedJ8499Prescription drug, oral, non chemotherapeutic, nosJ8502Injection, aprepitant (aponvie), 1 mgJ8510Busulfan; oral, 2 mgJ8515Cabergoline, oral, 0.25 mgJ8520Capecitabine, oral, 150 mgJ8521Capecitabine, oral, 500 mgJ8522Capecitabine, oral, 50 mg